FDA Will Reinspect, May Refuse Entry to Two Canada Fish Processors for HACCP Violations
The Food and Drug Administration may refuse entry of fish products from two Canadian processors for violations of seafood Hazard Analysis and Critical Control Point (HACCP) regulations, it said in two recently published warning letters. North Fish’s HACCP plans are inadequate for salted herring, dried salted white fish, and refrigerated cold smoked mackerel, rendering those products adulterated, FDA said (here). Fisherman's Market’s mackerel, mahi mahi, marlin, herring, shad, tuna, and vacuum packaged frozen cooked lobster, crab and shrimp products are adulterated for the same reason, it said (here).
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
FDA threatened to place both companies’ products on import alert and refuse them entry without physical examination. Because the violations are materially related to food safety, FDA said it would conduct reinspections of the facilities, and recommended the two companies notify their U.S. agents of possible reinspection fee liability.